Gouty Arthritis Market Global Industry Insights,
Trends, Outlook, and Opportunity Analysis, 2018-
2026
Gouty arthritis is characterized by intense joint pain due to deposition of uric acid crystals.
Symptoms of gouty arthritis include redness and swelling of joints and intense pain. The
condition can be treated with the help of medication. Uric acid is deposited either due to its
excess intake or body’s inability to process it leading to inflammation of joint sites such as
ankles and toes or wrist. Untreated gouty arthritis may damage joints or kidney as excessive
accumulation of uric acid crystals would lead to kidney stone, kidney failure. In most cases, it
is observed with other metabolic diseases or conditions such as hypertension, obesity, and
diabetes.
Request Sample Copy of Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/1368
High prevalence of associated chronic diseases to provide growth to gouty arthritis market
Other comorbidities such as hypertension is often associated with gout. As per study published
in Journal of Rheumatology in 2014, around 75% of gouty arthritis patient were reported to be
suffering from hypertension. Therefore patients suffering from chronic disease are at high risk of
developing gouty arthritis .High prevalence of gouty arthritis is expected to drive the growth for
global gouty arthritis market. According to study published in British Medical Journal in 2017,
prevalence of gouty arthritis is 1% to 10% globally. Furthermore, factors such as increasing
consumption of high protein food worldwide, linked with gouty arthritis and increasing
awareness amongst people for early treatment of disease are the factors boosting growth of
gouty arthritis market.
North America holds dominant position in gouty arthritis market
Regional segmentation of gouty arthritis market by Coherent Market Insights consist of North
America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is
expected to dominate gouty arthritis market, owing high prevalence of gouty arthritis in the
U.S. According to Centre for Disease Control and Prevention (CDC), an estimated 54.4 million